{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T20:54:28Z","timestamp":1790024068080,"version":"4.0.1"},"reference-count":112,"publisher":"Cambridge University Press (CUP)","issue":"6","license":[{"start":{"date-parts":[[2015,1,2]],"date-time":"2015-01-02T00:00:00Z","timestamp":1420156800000},"content-version":"unspecified","delay-in-days":7520,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Infect. Control Hosp. Epidemiol."],"published-print":{"date-parts":[[1994,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The azole antifungal agents represent a major advance in the management of superficial and systemic fungal infections. Itraconazole appears to have a broad spectrum of in vitro activity and is the first azole antifungal agent to have activity against Aspergillus species. Itraconazole acts primarily by impairing the synthesis of ergosterol, resulting in a defective fungal cell membrane with altered permeability and function. It is effective for a wide variety of mycotic infections and some fungal meningeal infections. Most adverse effects have been relatively minor and do not lead to discontinuation of therapy.<\/jats:p>","DOI":"10.1086\/646938","type":"journal-article","created":{"date-parts":[[2009,9,3]],"date-time":"2009-09-03T17:57:55Z","timestamp":1252000675000},"page":"397-410","source":"Crossref","is-referenced-by-count":41,"title":["Itraconazole: A New Triazole Antifungal Agent"],"prefix":"10.1017","volume":"15","author":[{"given":"Jerry M.","family":"Zuckerman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan R.","family":"Tunkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2015,1,2]]},"reference":[{"key":"S0195941700009930_bib024","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.32.9.1310"},{"key":"S0195941700009930_bib076","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1093\/clinids\/9.Supplement_1.S57","article-title":"A clinical trial of itraconazole in the treatment of deep mycoses and leishmaniasis","volume":"9","author":"Borelli","year":"1987","journal-title":"Rev Infect Dis"},{"key":"S0195941700009930_bib051","first-page":"36","article-title":"Treatment of vaginal candidosis: a comparative study of the efficacy and acceptability of itraconazole and clotrimazole","volume":"68","author":"Tobin","year":"1992","journal-title":"Genitourin Med"},{"key":"S0195941700009930_bib008","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/9.Supplement_1.S33"},{"key":"S0195941700009930_bib057","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/29.2.195"},{"key":"S0195941700009930_bib046","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/9.Supplement_1.S146"},{"key":"S0195941700009930_bib072","first-page":"809","article-title":"Histoplasmosis in the acquired immunodeficiency syndrome (AIDS): treatment with itraconazole and fluconazole","volume":"6","author":"Sharkey-Mathis","year":"1993","journal-title":"J Acquir Immune Defic Syndr"},{"key":"S0195941700009930_bib037","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1177\/030006059202000504","article-title":"A comparison of itraconazole and griseofulvin in the treatment of tinea corporis and tinea cruris: a double-blind study","volume":"20","author":"Panagiotidou","year":"1992","journal-title":"J Intern Med Res"},{"key":"S0195941700009930_bib043","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/0190-9622(90)70252-D","article-title":"Itraconazole in tinea versicolor: a review","volume":"23","author":"Delescluse","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"S0195941700009930_bib065","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(90)70263-H"},{"key":"S0195941700009930_bib093","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/0959-8049(92)90127-N","article-title":"Plasma itraconazole concentrations in neutropenic patients after reneated high-dose treatment","volume":"28","author":"Persat","year":"1992","journal-title":"Eur J Cancer"},{"key":"S0195941700009930_bib105","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1001\/jama.1993.03500120046022","article-title":"Itraconazole-didanosine excioient interaction","volume":"269","author":"Moreno","year":"1993","journal-title":"JAMA"},{"key":"S0195941700009930_bib050","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1128\/AAC.37.1.89","article-title":"Placebo-controlled trial of itraconazole for treatment of acute vaginal candidiasis","volume":"37","author":"Stein","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"S0195941700009930_bib034","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.1093\/clinids\/9.Supplement_1.S109","article-title":"Treatment of dermatophytoses and pityriasis versicolor with itraconazole","volume":"9","author":"Panconesi","year":"1987","journal-title":"Rev Infect Dis"},{"key":"S0195941700009930_bib007","first-page":"2581","article-title":"Effects of imidazole and triazole-derivative antifungal compounds on the growth and morphological development of Candida albicans hyphae","volume":"131","author":"Odds","year":"1985","journal-title":"J Gen Microbial"},{"key":"S0195941700009930_bib044","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1093\/clinids\/9.Supplement_1.S121","article-title":"Randdmized comparative clinical trial of itraconazole and selenium sulfide shampoo for the treatment of pityriasis versicolor","volume":"9","author":"Del Palacio-Hemanz","year":"1987","journal-title":"Rev Infect Dis"},{"key":"S0195941700009930_bib022","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-109-6-471"},{"key":"S0195941700009930_bib038","doi-asserted-by":"publisher","DOI":"10.1159\/000247498"},{"key":"S0195941700009930_bib025","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0028-2243(86)90109-7","article-title":"Itraconazole pharmacokinetics in the female genital tract: plasma and tissue levels in patients undergoing hysterectomy after a single dose of 200 mg itraconazole","volume":"23","author":"Larosa","year":"1986","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"S0195941700009930_bib079","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(90)70261-F"},{"key":"S0195941700009930_bib005","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12521036"},{"key":"S0195941700009930_bib019","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/BF00558308","article-title":"The effects of food and dose on the oral systemic availability of itraconazole in healthy subjects","volume":"36","author":"Van Perr","year":"1989","journal-title":"Eur J Clin Pharmacol"},{"key":"S0195941700009930_bib040","doi-asserted-by":"publisher","DOI":"10.1111\/j.1439-0507.1988.tb04435.x"},{"key":"S0195941700009930_bib018","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1128\/AAC.37.4.778","article-title":"Food interaction and steady-state pharmacokinetics of itraconazole capsules in healthy male volunteers","volume":"37","author":"Barone","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"S0195941700009930_bib063","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199202000-00007"},{"key":"S0195941700009930_bib052","first-page":"81","article-title":"Chronic vulvovaainal candidosis: the role of oral treatment","volume":"71","author":"Merkus","year":"1990","journal-title":"Br J Clin Practr Symp Suppl"},{"key":"S0195941700009930_bib059","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0163-4453(89)91178-X","article-title":"Experience with itraconazole in ctyptococcosis and aspergillosis","volume":"18","author":"Viviani","year":"1989","journal-title":"J Infect"},{"key":"S0195941700009930_bib042","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/9.Supplement_1.S131"},{"key":"S0195941700009930_bib036","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1365-4362.1989.tb02491.x","article-title":"Double-blind comparison of itraconazole with griseofulvin in the treatment of tinea corporis and tinea cruis","volume":"28","author":"Bourloid","year":"1989","journal-title":"Int J Dermatol"},{"key":"S0195941700009930_bib096","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0140-6736(92)90527-A","article-title":"Henatic iniurv associated with itraconazole~","volume":"340","author":"Lavrijsen","year":"1992","journal-title":"Lancet"},{"key":"S0195941700009930_bib006","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1128\/AAC.20.1.71","article-title":"Heterogenicity of action mechanisms among antimycotic imidazoles","volume":"20","author":"Sud","year":"1981","journal-title":"Antimicrob Agents Chemother"},{"key":"S0195941700009930_bib095","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/jac\/26.4.561","article-title":"Adverse events associated with itraconazole in 189 patients on chronic therapy","volume":"26","author":"Tucker","year":"1990","journal-title":"J Antimicrob Chemother"},{"key":"S0195941700009930_bib084","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0002-9343(93)90280-3","article-title":"Treatment of sporotrichosis with itraconazole","volume":"95","author":"Sharkey-Mathis","year":"1993","journal-title":"Am J Med"},{"key":"S0195941700009930_bib047","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0020-7292(91)90718-K","article-title":"Itraconazole versus placebo in the management of vaginal candidiasis","volume":"36","author":"Silva-Cruz","year":"1991","journal-title":"Int J Gynaecol Obstet"},{"key":"S0195941700009930_bib078","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1080\/02681219080000091","article-title":"Treatment of paracoccidioidomycosis with itraconazole","volume":"28","author":"Naranio","year":"1990","journal-title":"J Med Vet Mycol"},{"key":"S0195941700009930_bib112","doi-asserted-by":"publisher","DOI":"10.1093\/clind\/16.3.400"},{"key":"S0195941700009930_bib091","first-page":"84","article-title":"Safety and efficacy of itraconazole in preventing fungal infections in neutropenic patients","volume":"39","author":"Thunnissen","year":"1991","journal-title":"Neth I Med"},{"key":"S0195941700009930_bib077","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1093\/clinids\/9.Supplement_1.S51","article-title":"Itraconazole in the treatment of paracoccidioidomycosis: a preliminary report","volume":"9","author":"Restrepo","year":"1987","journal-title":"Rev Infect Dis"},{"key":"S0195941700009930_bib011","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/17.Supplement_2.S494"},{"key":"S0195941700009930_bib094","doi-asserted-by":"publisher","DOI":"10.1016\/0163-4453(91)90954-Q"},{"key":"S0195941700009930_bib100","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1001\/jama.1993.03500120051025","article-title":"Terfenadine-ketoconazole interaction, pharmacokinetic and electrocardiomanhic consequences","volume":"269","author":"Honig","year":"1993","journal-title":"JAMA"},{"key":"S0195941700009930_bib017","first-page":"50","article-title":"Pharmacokinetics of oral antifungals and their clinical implications","volume":"44","author":"Heykants","year":"1990","journal-title":"Br J Clin Pract"},{"key":"S0195941700009930_bib026","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0190-9622(88)70037-7","article-title":"Pharmacokinetic profile of orally administered itraconazole in human skin","volume":"18","author":"Cauwenbergh","year":"1988","journal-title":"J Am Acad Dermatol"},{"key":"S0195941700009930_bib098","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1128\/AAC.31.4.647","article-title":"Adrenal response to corticotropin therapy with itraconazole","volume":"31","author":"Phillips","year":"1987","journal-title":"Antimicrob Agents Chemother"},{"key":"S0195941700009930_bib066","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/9.Supplement_1.S87"},{"key":"S0195941700009930_bib107","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(87)91412-7"},{"key":"S0195941700009930_bib048","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/9.Supplement_1.S139"},{"key":"S0195941700009930_bib054","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/0190-9622(90)70256-H","article-title":"Treatment of oral candidosis with itraconazole: a review","volume":"23","author":"Blatchford","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"S0195941700009930_bib003","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0006-2952(87)90694-0","article-title":"Interaction of azole antifungal agents with cytochrome F450 purified from Saccharomyces cerevisiae microsomes","volume":"36","author":"Yoshida","year":"1987","journal-title":"Biochem Phamnacol"},{"key":"S0195941700009930_bib033","doi-asserted-by":"crossref","first-page":"s119","DOI":"10.1093\/clinids\/9.Supplement_1.S119","article-title":"Itraconazole in the treatment of tinea corporis: a pilot study","volume":"9","author":"Nuijten","year":"1987","journal-title":"Rev Infect Dis"},{"key":"S0195941700009930_bib014","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(90)90339-F"},{"key":"S0195941700009930_bib001","doi-asserted-by":"publisher","DOI":"10.1177\/106002809202600411"},{"key":"S0195941700009930_bib068","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1093\/clinids\/9.Supplement_1.S47","article-title":"Oral treatment of paracoccidioidomycosis and histoplasmosis with itraconazole in humans","volume":"9","author":"Negroni","year":"1987","journal-title":"Rev Infect Dis"},{"key":"S0195941700009930_bib070","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/0002-9343(92)90575-V","article-title":"Itraconazole therapy for blastomycosis and histoplasmosis","volume":"93","author":"Dismukes","year":"1992","journal-title":"Am J Med"},{"key":"S0195941700009930_bib092","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1439-0507.1989.tb02299.x","article-title":"Antifungal prophylaxis with itraconazole in prolonged neutropenia: correlation with plasma levels","volume":"32","author":"Boogaerts","year":"1989","journal-title":"Mycoses"},{"key":"S0195941700009930_bib032","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/9.Supplement_1.S100"},{"key":"S0195941700009930_bib031","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/9.Supplement_1.S104"},{"key":"S0195941700009930_bib020","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(87)70194-7"},{"key":"S0195941700009930_bib082","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/9.Supplement_1.S64"},{"key":"S0195941700009930_bib027","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(92)70102-L"},{"key":"S0195941700009930_bib062","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(90)70262-G"},{"key":"S0195941700009930_bib102","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1990.03450210088038"},{"key":"S0195941700009930_bib106","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S0140-6736(87)90873-7","article-title":"Interaction of cyclosporin and itraconazole","volume":"2","author":"Kwan","year":"1987","journal-title":"Lancet"},{"key":"S0195941700009930_bib103","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/14.1.165"},{"key":"S0195941700009930_bib090","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/9.Supplement_1.S77"},{"key":"S0195941700009930_bib069","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1439-0507.1989.tb02219.x","article-title":"Itraconazole in human histonlasmosis","volume":"32","author":"Negroni","year":"1989","journal-title":"Mycoses"},{"key":"S0195941700009930_bib073","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1439-0507.1992.tb00875.x","article-title":"Itraconazole in the treatment of histoplasmosis associated with AIDS","volume":"35","author":"Negroni","year":"1992","journal-title":"Mycoses"},{"key":"S0195941700009930_bib023","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1093\/clinids\/9.Supplement_1.S94","article-title":"Ketoconazole vs itraconazole for antifungal prophylaxis in patients with severe granulocytopenia: preliminary results of two nonrandomized studies","volume":"9","author":"Tricot","year":"1987","journal-title":"Rev Infect Dis"},{"key":"S0195941700009930_bib030","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.32.10.1595"},{"key":"S0195941700009930_bib012","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/9.Supplement_1.S15"},{"key":"S0195941700009930_bib109","doi-asserted-by":"crossref","first-page":"327","DOI":"10.7326\/0003-4819-113-4-327","article-title":"Cyclosporine and itraconazole interaction in heart and lung transplant recipients","volume":"113","author":"Kramer","year":"1990","journal-title":"Ann Intern Med"},{"key":"S0195941700009930_bib058","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4362.1991.tb02648.x"},{"key":"S0195941700009930_bib085","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1093\/clinids\/17.2.210","article-title":"Systemic sporotrichosis treated with itraconazole","volume":"17","author":"Winn","year":"1993","journal-title":"Clin Infect Dis"},{"key":"S0195941700009930_bib029","doi-asserted-by":"publisher","DOI":"10.1111\/j.1439-0507.1989.tb02296.x"},{"key":"S0195941700009930_bib089","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/0190-9622(90)70259-K","article-title":"Itraconazole treatment of phaeohyphomycosis","volume":"23","author":"Sharkey","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"S0195941700009930_bib039","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1365-2230.1990.tb02041.x","article-title":"Itraconazole in the treatment of superficial mycoses-a double-blind study vs. placebo","volume":"15","author":"Roseeuw","year":"1990","journal-title":"Clin Exp Dermatol"},{"key":"S0195941700009930_bib108","first-page":"267","article-title":"Interaction of cyclosporin and itraconazole","volume":"2","author":"Shaw","year":"1987","journal-title":"Lancet"},{"key":"S0195941700009930_bib067","doi-asserted-by":"publisher","DOI":"10.1111\/j.1439-0507.1988.tb03986.x"},{"key":"S0195941700009930_bib064","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199203193261203"},{"key":"S0195941700009930_bib002","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/14.Supplement_1.S161"},{"key":"S0195941700009930_bib086","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4362.1991.tb04878.x"},{"key":"S0195941700009930_bib061","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1989.00390100107024"},{"key":"S0195941700009930_bib081","doi-asserted-by":"crossref","first-page":"108","DOI":"10.7326\/0003-4819-112-2-108","article-title":"Itraconazole therapy for chronic coccidioidal meningitis","volume":"112","author":"Tucker","year":"1990","journal-title":"Ann Intern Med"},{"key":"S0195941700009930_bib049","first-page":"77","article-title":"Itracdnazole: a single-day oral treatment for acute vulvovaginal candidosis","volume":"71","author":"Wesel","year":"1990","journal-title":"Br J Clin Pract Symp Suppl"},{"key":"S0195941700009930_bib099","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/0002-9343(93)90317-I","article-title":"Syncope and cardiac arrhythmia due to an interaction between itraconazole and terfenadine","volume":"95","author":"Crane","year":"1993","journal-title":"Am\/ Med"},{"key":"S0195941700009930_bib015","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/9.Supplement_1.S71"},{"key":"S0195941700009930_bib041","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/9.Supplement_1.S134"},{"key":"S0195941700009930_bib083","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1986.01660160069021"},{"key":"S0195941700009930_bib056","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1988.tb03229.x"},{"key":"S0195941700009930_bib087","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1001\/archderm.1989.01670230082014","article-title":"Cutaneous leishmaniasis. Treatment with itraconazole","volume":"125","author":"Albanese","year":"1989","journal-title":"Arch Dermatol"},{"key":"S0195941700009930_bib055","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1097\/00002030-199111000-00014","article-title":"Itraconazole versus ketaconazole in the treatment of oral and oesophageal candidosis in patients infected with HIV","volume":"5","author":"Smith","year":"1991","journal-title":"AIDS"},{"key":"S0195941700009930_bib104","first-page":"7","article-title":"Itraconazole","volume":"35","year":"1993","journal-title":"Medical Letter"},{"key":"S0195941700009930_bib110","doi-asserted-by":"publisher","DOI":"10.1093\/clind\/15.5.886"},{"key":"S0195941700009930_bib088","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4362.1990.tb02593.x"},{"key":"S0195941700009930_bib111","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-116-6-525"},{"key":"S0195941700009930_bib045","doi-asserted-by":"crossref","first-page":"310","DOI":"10.2165\/00003495-198937030-00003","article-title":"Clissold SE Itraconazole: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in superficial and systemic mycoses","volume":"37","author":"Grant","year":"1989","journal-title":"Drugs"},{"key":"S0195941700009930_bib101","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1001\/jama.1991.03470170063023","article-title":"Torsade de pointes occurring in association with terfenadine use","volume":"266","author":"Mathews","year":"1991","journal-title":"JAMA"},{"key":"S0195941700009930_bib035","first-page":"326","article-title":"Itraconazole therapy in dermatomycosis and vaginal canhidiasis: efficacy and adverse effects profile in a large multicenter study","volume":"5","author":"Akantara","year":"1988","journal-title":"Adv Ther"},{"key":"S0195941700009930_bib004","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/2.4.520"},{"key":"S0195941700009930_bib013","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.26.1.5"},{"key":"S0195941700009930_bib028","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1093\/clinids\/9.Supplement_1.S43","article-title":"Itraconazole: pharmacologic studies in animals and humans","volume":"9","author":"Van Cauteren","year":"1987","journal-title":"Rev Infect Dis"},{"key":"S0195941700009930_bib060","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/0190-9622(90)70260-O","article-title":"European experience with itraconazole in systemic mycoses","volume":"23","author":"Viviani","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"S0195941700009930_bib071","doi-asserted-by":"crossref","first-page":"861","DOI":"10.7326\/0003-4819-103-6-861","article-title":"Treatment of blastomycosis and histoplasmosis with ketoconazole: results of a prospective randomized clinical trial","volume":"103","author":"Dismukes","year":"1985","journal-title":"Ann Intern Med"},{"key":"S0195941700009930_bib053","first-page":"374","article-title":"The value of chronic suppressive therapy with itraconazole versus clotrimazole in women with recurrent vaginal candidiasis","volume":"68","author":"Fong","year":"1992","journal-title":"Genitourin Med"},{"key":"S0195941700009930_bib097","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.35.4.707"},{"key":"S0195941700009930_bib010","doi-asserted-by":"crossref","first-page":"S170","DOI":"10.1093\/clinids\/14.Supplement_1.S170","article-title":"Future directions of antifungal chemotherapy","volume":"14","author":"Graybill","year":"1992","journal-title":"Clin Infect Dis"},{"key":"S0195941700009930_bib074","doi-asserted-by":"crossref","first-page":"610","DOI":"10.7326\/0003-4819-118-8-199304150-00006","article-title":"Prevention of relapse of histoplasmosis with itraconazole in patients with the acquired immunodeficiency syndrome","volume":"118","author":"Wheat","year":"1993","journal-title":"Ann Intern Med"},{"key":"S0195941700009930_bib075","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/00005792-199011000-00004","article-title":"Disseminated histoplasmosis in the acquired immune deficiency syndrome: clinical findings, diagnosis and treatment, and review of the literature","volume":"69","author":"Wheat","year":"1990","journal-title":"Medicine"},{"key":"S0195941700009930_bib009","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1365-2133.1986.tb05721.x","article-title":"Itraconazole therapy in pityriasis versicolor","volume":"115","author":"Del Palacio-Hemanz","year":"1986","journal-title":"Br J Derm"},{"key":"S0195941700009930_bib080","doi-asserted-by":"publisher","DOI":"10.1378\/chest.100.3.682"},{"key":"S0195941700009930_bib021","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/j.2042-7158.1992.tb05478.x","article-title":"The nharmacokinetics of oral itraconazole in AIDS patients","volume":"44","author":"Smith","year":"1992","journal-title":"J Pharm Phamtacol"},{"key":"S0195941700009930_bib016","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/0002-9343(89)90475-0","article-title":"Treatment of invasive aspergillosis with itraconazole","volume":"86","author":"Denning","year":"1989","journal-title":"Am J Med"}],"container-title":["Infection Control &amp; Hospital Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0195941700009930","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T06:28:59Z","timestamp":1717482539000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0195941700009930\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994,6]]},"references-count":112,"aliases":["10.2307\/30145593"],"journal-issue":{"issue":"6","published-print":{"date-parts":[[1994,6]]}},"alternative-id":["S0195941700009930"],"URL":"https:\/\/doi.org\/10.1086\/646938","relation":{},"ISSN":["0899-823X","1559-6834"],"issn-type":[{"value":"0899-823X","type":"print"},{"value":"1559-6834","type":"electronic"}],"subject":[],"published":{"date-parts":[[1994,6]]}}}